Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
79,796,561
-
Share change
-
-2,123,652
-
Total reported value
-
$1,330,583,231
-
Put/Call ratio
-
484%
-
Price per share
-
$16.67
-
Number of holders
-
217
-
Value change
-
-$62,889,463
-
Number of buys
-
116
-
Number of sells
-
104
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2016
As of 31 Dec 2016,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,796,561 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Camber Capital Management LLC, STATE STREET CORP, BlackRock Fund Advisors, FRONTIER CAPITAL MANAGEMENT CO LLC, D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, Consonance Capital Management LP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
217
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.